Professor Adam Guastella

Principle Research Fellow
Psychiatry, School of Medical Sciences
Brain & Mind Research Institute

Telephone +61 2 9351 0539
Fax +61 2 9351 0855

Map

Biographical details

Professor Adam Guastella is a Clinical Psychologist and NHMRC Career Development Fellow at the Brain and Mind Centre and Central Clinical School, School of Medicine.

Professor Guastella has an established track record in human translational neuroscience. His primary interest is in using neuroscience to inform and develop novel treatments for young patients with mental health problems. This research has led him to study the neurobiology of social behaviour and how this neurobiology relates to symptoms (e.g., reduced theory of mind, social anxiety) in people presenting with a range of mental illnesses (anxiety, autism, psychosis, substance dependence). His research may take the form of cognitive-experimental investigations aimed at understanding how biology can interact with psychological processes to cause, maintain and recover from mental health problems. It may also involve clinical trials to demonstrate efficacy of intervention to treatment psychiatric illness.

To illustrate, Prof. Guastella initiated a program of research that showed the powerful enhancing effects of oxytocin administration on face-perception and the cognitive processing of social-stimuli in humans. Subsequently, Prof Guastella's team was the first in the world to show that a medication could be used as a treatment for social impairments in young children with autism. This program of research now focuses on understanding who responds to treatment, why and now incorporates multi-site trials across europe, asia and australia. It involves first in world trials of targets to treat social impairment and development of new devices and behavioural interventions to enhance response. This research advances potential new treatments and our basic understanding for evolutionary and biosocial theories of bonding and attachment in humans and may lead an exciting new treatment approach for mental health problems. Much of this work is conducted within the Autism Clinic for Translational Research.

Prof Guastella also treats young patients with social anxiety and the group Cognitive-Behaviour Therapy programs have treated over 400 young people in the inner west. These programs advance knowledge about how humans overcome fear and there are a range of marker and treatment studies. For example, Prof Guastella showed that D-Cycloserine (DCS) facilitates fear-extinction in humans. Consisting of experimental investigations of fear-extinction in humans and large clinical treatment trials for social anxiety these trials have shown that the administration of a medication before psychological therapy enhances treatment outcomes for anxiety. This has the potential to revolutionize how mental health professionals treat anxiety disorders in the community.

Research interests

Autism, Social Anxiety, Social Neurobiology, Cognitive-Behaviour Therapy

Teaching and supervision

Masters level course: Neuroscience and Cognitive Behaviour Therapy

Current research students

Project title Research student
Predicting Treatment Response after Cognitive Behavioral Therapy for Social Anxiety Disorder using change in disability and random forest modelling Shin Ho PARK

Current projects

Oxytocin, autism and its treatment in toddlers: Multi-site large scale investigations

Novel interventions and assessments for adults with autism

Social anxiety and Cognitve-Behaviour Therapy

Early psychosis and social cognition and its treatment

Awards and honours

Tracey Goodall Early Career Award (Australian Association of Cognitive Behaviour Therapy)

Aubrey Lewis Early Career Award (Biological Psychiatry Australia)

International links

China

(UESTC) Multi-site clinical trials

Norway

(Olso University) Multi-site Clinical Trials

United States

(Emory University Duke University) Multi-Site Clinical Trials

Selected grants

2015

  • Does the use of intranasal oxytocin improve emotional functioning and reduce carer burden in Alzheimer’s Disease; Naismith S, Guastella A, McCade D; The Judith Jane Mason and Harold Stannett Williams Memorial Foundation/Medical and Scientific Research Grants.
  • Understanding biological pathways underlying social behaviour in humans; Guastella A, Hickie I, Young L, Banati R, Djupesland P, Lagopoulos J, Gregoire M; Australian Research Council (ARC)/Linkage Projects (LP).
  • Serotonin transporter methylation and brain development: studies in autism and interaction with oxytocin; Booij L, Guastella A; DVC Research/International Research Collaboration Award (IRCA).
  • A Therapeutic Intervention in Alzheimer’s Disease; Intranasal Oxytocin Administration to Enhance motion Processing and Reduce Caregiver Burden; McCade D, Naismith S, Guastella A; Alzheimers Australia Dementia Research Foundation/Project Grant.
  • Oxytocin and Health; Guastella A; DVC Research/Bridging Support Grant.

2014

  • Clinical CDF Level 2 - Determining the role of oxytocin and associated analogues in treatments for social dysfunction; Guastella A; National Health and Medical Research Council (NHMRC)/Career Development Fellowships.
  • Clinical observation and comprehensive psychophysiological recording and behavioural coding equipment; Guastella A, de Rosnay M, Einfeld S, Glozier N, Hawes D, Hickie I, Lagapolos J, Matthews S, Menzies R, Morley K, Naismith S; National Health and Medical Research Council (NHMRC)/Equipment Grants.

2013

  • Optimising early interventions for young people with emerging mood disorder; Hickie I, McGorry P, Christensen H, Berk M, Naismith S, Glozier N, Burns J, Guastella A, Davey C, Amminger P; National Health and Medical Research Council (NHMRC)/Centres of Research Excellence.
  • A course of oxytocin to improve social communication in young children with autism; Guastella A, Whitehouse A, Gregory S; National Health and Medical Research Council (NHMRC)/Project Grants.
  • Neuroimaging oxytocin modulated plasticity, response markers and implication for treatment of Autism Spectrum Disorders and co-morbid intellectual disability; Guastella A, Johnston B; Endeavour Foundation/Research Support.

2012

  • Evaluation of a melanocortin agonist to improve social cognition in ASD; Guastella A, Hickie I, Young L; Simons Foundation (USA)/Research Support.
  • Investigating oxytocin to improve social difficulties in patients with autism; Guastella A; BUPA Foundation (Australia) Limited/Grants Program.

2011

  • Examination of the Cognitive and Biological Circuitry Underlying Social-Cognitive Training in First Episode Psychosis; Guastella A, Langdon R, Scott E, Ward P, Naismith S, Redoblado Hodge M; Australian Research Council (ARC)/Linkage Projects (LP).
  • LNK: 2011/Round2/ARC LP110200562, Attentional and conditioning mechanisms that mediate overcoming anxiety (Pearl 100) - Attentional and Conditioning Mechanisms that Mediate Overcoming Anxiety; Guastella A, MacLeod C, Scott E; Australian Research Council (ARC)/Linkage Projects (LP).

2010

  • LNK: 2011/Round1/ARC Linkage Project LP110100513 The Impact of Oxytocin (OT) on Social Cognition and; Redoblado Hodge M, Naismith S, Kelly A, Guastella A; The Clinical Centre/Project Support.
  • Oxytocin treatment for Prader-Willi Syndrome; Einfeld S, Smith A, Guastella A, Smith A; National Health and Medical Research Council (NHMRC)/Project Grants.
  • The effects of Oxytocin on Social Cognition in Schizophrenia; Guastella A, Langdon R, Redoblado Hodge M, Ward P, Scott E; National Health and Medical Research Council (NHMRC)/Project Grants.
  • A course of oxytocin nasal spray to improve social-communication in young people with autism; Guastella A, Einfeld S, Gray K, Rinehart N; National Health and Medical Research Council (NHMRC)/Project Grants.

2009

  • A Trial of Oxytocin To Improve Behaviour and Cognition in Prader-Willi Syndrome; Einfeld S, McGregor I, Guastella A, Smith A; Foundation for Prader-Willi Research/Research Grant.
  • The effects of oxytocin nasal spray on mechanisms of social-communication in young people with autism; Guastella A, Einfeld S, Reinhart N, Gray K, Lambert T, Tonge B; National Health and Medical Research Council (NHMRC)/Project Grants.
  • Randomised, double-blind, placebo controlled trial of lithium carbonate for the management of human cannabis withdrawal; Lintzeris N, McGregor I, Winstock A, Guastella A; National Health and Medical Research Council (NHMRC)/Project Grants.
  • The effect of Oxytocin on the processing of positive and threatening social cues; Guastella A; DVC Research/Bridging Support Grant.
  • D-Cycloserine Augmentation of Psychological Treatments for young Adults with Social Anxiety Disorder; Guastella A; DVC Research/Bridging Support Grant.

Selected publications

Download citations: PDF RTF Endnote

Journals

  • Alvares, G., Quintana, D., Hickie, I., Guastella, A. (2016). Autonomic nervous system dysfunction in psychiatric disorders and the impact of psychotropic medications: a systematic review and meta-analysis. Journal of Psychiatry & Neuroscience, 40(6), 1-16. [More Information]
  • Iorfino, F., Alvarez, G., Guastella, A., Quintana, D. (2016). Cold face test-induced increases in heart rate variability are abolished by engagement in a social cognition task. Journal of Psychophysiology, 30(1), 38-46. [More Information]
  • Scott, E., Robillard, R., Hermens, D., Naismith, S., Rogers, N., Ip, T., White, D., Guastella, A., Whitwell, B., Smith, K., Hickie, I. (2016). Dysregulated sleep–wake cycles in young people are associated with emerging stages of major mental disorders. Early Intervention in Psychiatry, 10(1), 63-70. [More Information]
  • Guastella, A., Hickie, I. (2016). Oxytocin Treatment, Circuitry and Autism: A Critical Review of the Literature Placing Oxytocin into the Autism Context. Biological Psychiatry, 79(3), 234-242. [More Information]
  • Yatawara, C., Einfeld, S., Hickie, I., Davenport, T., Guastella, A. (2016). The effect of oxytocin nasal spray on social interaction deficits observed in young children with autism: a randomized clinical crossover trial. Molecular Psychiatry, On-line First: 27 Oct 2015(doi:10.1038/mp.2015.162), 1-7. [More Information]
  • Quintana, D., Guastella, A., Westlye, L., Andreassen, O. (2016). The promise and pitfalls of intranasally administering psychopharmacological agents for the treatment of psychiatric disorders. Molecular Psychiatry, 21(1), 29-38. [More Information]
  • Cacciotti-Saija, C., Langdon, R., Ward, P., Hickie, I., Scott, E., Naismith, S., Moore, L., Alvares, G., Redoblado-Hodge, M., Guastella, A. (2015). A Double-blind Randomized Controlled Trial of Oxytocin Nasal Spray and Social Cognition Training for Young People With Early Psychosis. Schizophrenia Bulletin, 41(2), 483-493. [More Information]
  • Guastella, A., Ward, P., Hickie, I., Shahrestani, S., Redoblado Hodge, M., Scott, E., Langdon, R. (2015). A single dose of oxytocin nasal spray improves higher-order social cognition in schizophrenia. Schizophrenia Research, 168(3), 628-633. [More Information]
  • Robillard, R., Hermens, D., Naismith, S., White, D., Rogers, N., Ip, T., Mullin, S., Alvares, G., Guastella, A., Smith, K., Whitwell, B., Southan, J., Glozier, N., Scott, E., Hickie, I., et al (2015). Ambulatory sleep-wake patterns and variability in young people with emerging mental disorders. Journal of Psychiatry & Neuroscience, 40(1), 28-37. [More Information]
  • Chen, N., Clarke, P., Watson, T., MacLeod, C., Guastella, A. (2015). Attentional Bias Modification Facilitates Attentional Control Mechanisms: Evidence from Eye Tracking. Biological Psychology, 104, 139-146. [More Information]
  • Masi, A., Quintana, D., Glozier, N., Lloyd, A., Hickie, I., Guastella, A. (2015). Cytokine aberrations in autism spectrum disorder: a systematic review and meta-analysis. Molecular Psychiatry, 20(4), 440-446. [More Information]
  • Purcell, R., Jorm, A., Hickie, I., Yung, A., Pantelis, C., Aminger, G., Glozier, N., Killackey, E., Phillips, L., Wood, S., Scott, E., Hermens, D., Guastella, A., Kenyon, A., Nichles, A., Zmicerevska, N., et al (2015). Demographic and clinical characteristics of young people seeking help at youth mental health services: baseline findings of the Transitions Study. Early Intervention in Psychiatry, 9(6), 487-497. [More Information]
  • Quintana, D., Alvares, G., Hickie, I., Guastella, A. (2015). Do delivery routes of intranasally administered oxytocin account for observed effects on social cognition and behavior? A two-level model. Neuroscience and Biobehavioral Reviews, 49, 182-192. [More Information]
  • Shahrestani, S., Stewart, E., Quintana, D., Hickie, I., Guastella, A. (2015). Heart rate variability during adolescent and adult social interactions: A meta-analysis. Biological Psychology, 105, 43-50. [More Information]
  • Chen, N., Thomas, L., Clarke, P., Hickie, I., Guastella, A. (2015). Hyperscanning and avoidance in social anxiety disorder: The visual scanpath during public speaking. Psychiatry Research, 225(3), 667-672. [More Information]
  • Masi, A., Lampit, A., Glozier, N., Hickie, I., Guastella, A. (2015). Predictors of placebo response in pharmacological and dietary supplement treatment trials in pediatric autism spectrum disorder: a meta-analysis. Translational Psychiatry, 5, 1-9. [More Information]
  • Howlin, P., Arciuli, J., Begeer, S., Brock, J., Clarke, K., Costley, D., Di Rita, P., Falkmer, T., Glozier, N., Gray, K., Guastella, A., Horstead, S., Rice, L., Stancliffe, R., West, S., Yam, C., Einfeld, S. (2015). Research on adults with autism spectrum disorder: Roundtable report. Journal of Intellectual and Developmental Disability, 40(5), 388-393. [More Information]
  • Guastella, A., Gray, K., Rinehart, N., Alvarez, G., Tonge, B., Hickie, I., Keating, C., Cacciotti-Saija, C., Einfeld, S. (2015). The effects of a course of intranasal oxytocin on social behaviors in youth diagnosed with autism spectrum disorders: a randomized controlled trial. Journal of Child Psychology and Psychiatry, 56(4), 444-452. [More Information]
  • Purcell, R., Jorm, A., Hickie, I., Yung, A., Pantelis, C., Amminger, G., Glozier, N., Killackey, E., Phillips, L., Wood, S., Scott, E., Kenyon, A., Nichles, A., Zmicerevska, N., Hermens, D., Guastella, A., et al (2015). Transitions Study of predictors of illness progression in young people with mental ill health: study methodology. Early Intervention in Psychiatry, 9(1), 38-47. [More Information]
  • O'Dea, B., Glozier, N., Purcell, R., McGorry, P., Scott, J., Feilds, K., Hermens, D., Buchanan, J., Scott, E., Yung, A., Guastella, A., Hickie, I., et al (2014). A cross-sectional exploration of the clinical characteristics of disengaged (NEET) young people in primary mental healthcare. BMJ Open, 4(12), 1-8. [More Information]
  • Einfeld, S., Smith, E., McGregor, I., Steinbeck, K., Taffe, J., Rice, L., Horstead, S., Rogers, N., Hodge, M., Guastella, A. (2014). A Double-Blind Randomized Controlled Trial of Oxytocin Nasal Spray in Prader Willi Syndrome. American Journal of Medical Genetics. Part A, 164A (9), 2232-2239. [More Information]
  • Chen, N., Clarke, P., Watson, T., MacLeod, C., Guastella, A. (2014). Biased Saccadic Responses to Emotional Stimuli in Anxiety: An Antisaccade Study. PloS One, 9(2), 1-7. [More Information]
  • Scott, J., Scott, E., Hermens, D., Naismith, S., Guastella, A., White, D., Whitwell, B., Lagopoulos, J., Hickie, I. (2014). Functional impairment in adolescents and young adults with emerging mood disorders. British Journal of Psychiatry, 205(5), 362-368. [More Information]
  • Shahrestani, S., Stewart, L., Quintana, D., Hickie, I., Guastella, A. (2014). Heart rate variability during social interactions in children with and without psychopathology: a meta-analysis. Journal of Child Psychology and Psychiatry, 55(9), 981-989. [More Information]
  • Alvares, G., Balleine, B., Guastella, A. (2014). Impairments in Goal-Directed Actions Predict Treatment Response to Cognitive-Behavioral Therapy in Social Anxiety Disorder. PloS One, 9(4), 1-7. [More Information]
  • Christensen, H., Mackinnon, A., Batterham, P., O'Dea, B., Guastella, A., Griffiths, K., Eagleson, C., Hehir, K., Kenardy, J., Bennett, K., Hickie, I. (2014). The effectiveness of an online e-health application compared to attention placebo or Sertraline in the treatment of Generalised Anxiety Disorder. Internet Interventions, 1(4), 169-174. [More Information]
  • Carson, D., Guastella, A., Taylor, E., McGregor, I. (2013). A brief history of oxytocin and its role in modulating psychostimulant effects. Journal of Psychopharmacology, 27(3), 231-247. [More Information]
  • Quintana, D., McGregor, I., Guastella, A., Malhi, G., Kemp, A. (2013). A Meta-Analysis on the Impact of Alcohol Dependence on Short-Term Resting-State Heart Rate Variability: Implications for Cardiovascular Risk. Alcoholism: Clinical and Experimental Research, 37(S1), E23-E29. [More Information]
  • Quintana, D., Kemp, A., Alvares, G., Guastella, A. (2013). A role for autonomic cardiac control in the effects of oxytocin on social behavior and psychiatric illness. Frontiers in Neuroscience, 7(April 2013), 1-9. [More Information]
  • Hickie, I., Scott, E., Hermens, D., Naismith, S., Guastella, A., Kaur, M., Sidis, A., Whitwell, B., Glozier, N., Davenport, T., et al (2013). Applying clinical staging to young people who present for mental health care. Early Intervention in Psychiatry, 7(1), 31-43. [More Information]
  • Clarke, P., MacLeod, C., Guastella, A. (2013). Assessing the role of spatial engagement and disengagement of attention in anxiety-linked attentional bias: a critique of current paradigms and suggestions for future research directions. Anxiety Stress and Coping, 26(1), 1-19. [More Information]
  • Hickie, I., Scott, J., Hermens, D., Scott, E., Naismith, S., Guastella, A., Glozier, N., McGorry, P. (2013). Clinical classification in mental health at the cross-roads: which direction next? BMC Medicine, 11(1), 1-14. [More Information]
  • Wudarczyk, O., Earp, B., Guastella, A., Savulescu, J. (2013). Could intranasal oxytocin be used to enhance relationships? Research imperatives, clinical policy, and ethical considerations. Current Opinion in Psychiatry, 26(5), 474-484. [More Information]
  • Scott, E., Hermens, D., Naismith, S., Guastella, A., De Regt, T., White, D., Lagopoulos, J., Hickie, I. (2013). Distinguishing young people with emerging bipolar disorders from those with unipolar depression. Journal of Affective Disorders, 144(3), 208-215. [More Information]
  • Scott, E., Hermens, D., Naismith, S., Guastella, A., White, D., Whitwell, B., Lagopoulos, J., Scott, J., Hickie, I. (2013). Distress and disability in young adults presenting to clinical services with mood disorders. International Journal of Bipolar Disorders, 1, 1-8. [More Information]
  • McCade, D., Savage, G., Guastella, A., Lewis, S., Naismith, S. (2013). Emotion Recognition Deficits Exist in Mild Cognitive Impairment, But Only in the Amnestic Subtype. Psychology and Aging, 28(3), 840-852. [More Information]
  • McCade, D., Savage, G., Guastella, A., Hickie, I., Lewis, S., Naismith, S. (2013). Emotion Recognition in Mild Cognitive Impairment: Relationship to Psychosocial Disability and Caregiver Burden. Journal of Geriatric Psychiatry and Neurology, 26(3), 165-173. [More Information]
  • Hickie, I., Hermens, D., Naismith, S., Guastella, A., Glozier, N., Scott, J., Scott, E. (2013). Evaluating differential developmental trajectories to adolescent-onset mood and psychotic disorders. BMC Psychiatry, 13(1), 1-11. [More Information]
  • Liu, J., Guastella, A., Dadds, M. (2013). Exploring the role of intra-nasal oxytocin on the partner preference effect in humans. Psychoneuroendocrinology, 38(4), 587-591. [More Information]
  • Quintana, D., Guastella, A., McGregor, I., Hickie, I., Kemp, A. (2013). Heart rate variability predicts alcohol craving in alcohol dependent outpatients: Further evidence for HRV as a psychophysiological marker of self-regulation. Drug and Alcohol Dependence, 132(1-2), 395-398. [More Information]
  • Quintana, D., Guastella, A., McGregor, I., Hickie, I., Kemp, A. (2013). Moderate alcohol intake is related to increased heart rate variability in young adults: Implications for health and well-being. Psychophysiology, 50(12), 1202-1208. [More Information]
  • Hermens, D., Naismith, S., Lagopoulos, J., Lee, R., Guastella, A., Scott, E., Hickie, I. (2013). Neuropsychological profile according to the clinical stage of young persons presenting for mental health care. BMC Psychology, 1, 1-9. [More Information]
  • Guastella, A., Hickie, I., McGuinness, M., Otis, M., Woods, E., Disinger, H., Chan, K., Chen, T., Banati, R. (2013). Recommendations for the standardisation of oxytocin nasal administration and guidelines for its reporting in human research. Psychoneuroendocrinology, 38(5), 612-625. [More Information]
  • Alvares, G., Quintana, D., Kemp, A., van Zwieten, A., Balleine, B., Hickie, I., Guastella, A. (2013). Reduced heart rate variability in social anxiety disorder: associations with gender and symptom severity. PloS One, 8(7), 1-8. [More Information]
  • van Zwieten, A., Meyer, J., Hermens, D., Hickie, I., Hawes, D., Glozier, N., Naismith, S., Scott, E., Lee, R., Guastella, A. (2013). Social cognition deficits and psychopathic traits in young people seeking mental health treatment. PloS One, 8(7), 1-9. [More Information]
  • Guastella, A., Hermens, D., van Zwieten, A., Naismith, S., Lee, R., Cacciotti-Saija, C., Scott, E., Hickie, I. (2013). Social cognitive performance as a marker of positive psychotic symptoms in young people seeking help for mental health problems. Schizophrenia Research, 149(1-3), 77-82. [More Information]
  • Shahrestani, S., Kemp, A., Guastella, A. (2013). The Impact of a Single Administration of Intranasal Oxytocin on the Recognition of Basic Emotions in Humans: A Meta-Analysis. Neuropsychopharmacology, 38(10), 1929-1936. [More Information]
  • Guastella, A., Alvares, G., Hickie, I., Chan, K., Chen, T., Banati, R. (2013). Unitary hormonal models, peripheral markers, and evaluation of response to drug: A response to Weisman and Feldman. Psychoneuroendocrinology, 38, 627-628. [More Information]
  • Lowe (nee Thompson), R., Guastella, A., Chen, N., Menzies, R., Packman, A., O'Brian, S., Onslow, M. (2012). Avoidance of eye gaze by adults who stutter. Journal of Fluency Disorders, 37(4), 263-274. [More Information]
  • Chen, N., Clarke, P., MacLeod, C., Guastella, A. (2012). Biased Attentional Processing of Positive Stimuli in Social Anxiety Disorder: An Eye Movement Study. Cognitive Behaviour Therapy, 41(2), 96-107. [More Information]
  • Clarke, P., Hickie, I., Scott, E., Guastella, A. (2012). Clinical staging model applied to young people presenting with social anxiety. Early Intervention in Psychiatry, 6(3), 256-264. [More Information]
  • Liu, J., Guastella, A., Dadds, M. (2012). Effects of oxytocin on human social approach measured using intimacy equilibriums. Hormones and Behavior, 62(5), 585-591. [More Information]
  • Quintana, D., Guastella, A., Outhred, T., Hickie, I., Kemp, A. (2012). Heart Rate Variability is Associated With Emotion Recognition: Direct Evidence for a Relationship Between the Autonomic Nervous System and Social Cognition. International Journal of Psychophysiology, 86(2), 168-172. [More Information]
  • Bryant, R., Hung, L., Guastella, A., Mitchell, P. (2012). Oxytocin as a moderator of hypnotizability. Psychoneuroendocrinology, 37(1), 162-166. [More Information]
  • Kemp, A., Quintana, D., Kuhnert, R., Griffiths, K., Hickie, I., Guastella, A. (2012). Oxytocin increases heart rate variability in humans at rest: implications for social approach-related motivation and capacity for social engagement. PloS One, 7(8), 1-6. [More Information]
  • Alvares, G., Chen, N., Balleine, B., Hickie, I., Guastella, A. (2012). Oxytocin selectively moderates negative cognitive appraisals in high trait anxious males. Psychoneuroendocrinology, 37(12), 2022-2031. [More Information]
  • Clarke, P., Chen, N., Guastella, A. (2012). Prepared for the Best: Readiness To Modify Attentional Processing and Reduction in Anxiety Vulnerability in Response to Therapy. Emotion, 12(3), 487-494. [More Information]
  • Scott, E., Hermens, D., Glozier, N., Naismith, S., Guastella, A., Hickie, I. (2012). Targeted primary care-based mental health services for young Australians. Medical Journal of Australia, 196(2), 136-140. [More Information]
  • Scott, E., Hermens, D., Naismith, S., White, D., Whitwell, B., Guastella, A., Glozier, N., Hickie, I. (2012). Thoughts of death or suicidal ideation are common in young people aged 12 to 30 years presenting for mental health care. BMC Psychiatry, 12(December 2012), 1-6. [More Information]
  • Guastella, A., Kenyon, A., Unkelbach, C., Alvares, G., Hickie, I. (2011). Arginine Vasopressin selectively enhances recognition of sexual cues in male humans. Psychoneuroendocrinology, 36(2), 294-297. [More Information]
  • Kemp, A., Guastella, A. (2011). The Role of Oxytocin in Human Affect: A Novel Hypothesis. Current Directions in Psychological Science, 20(4), 222-231.
  • Kemp, A., Guastella, A. (2011). The Role of Oxytocin in Human Affect: A Novel Hypothesis. Current Directions in Psychological Science, 20(4), 222-231. [More Information]
  • Alvares, G., Hickie, I., Guastella, A. (2010). Acute effects of intranasal oxytocin on subjective and behavioral responses to social rejection. Experimental and Clinical Psychopharmacology, 18(4), 316-321. [More Information]
  • Guastella, A., Kenyon, A., Alvares, G., Carson, D., Hickie, I. (2010). Intranasal Arginine Vasopressin Enhances the Encoding of Happy and Angry Faces in Humans. Biological Psychiatry, 67(12), 1220-1222. [More Information]
  • Guastella, A., Einfeld, S., Gray, K., Rinehart, N., Tonge, B., Lambert, T., Hickie, I. (2010). Intranasal Oxytocin Improves Emotion Recognition in Youth with Autism Spectrum Disorders. Biological Psychiatry, 67, 692-694. [More Information]
  • Carson, D., Cornish, J., Guastella, A., Hunt, G., McGregor, I. (2010). Oxytocin decreases methamphetamine self-administration, methamphetamine hyperactivity, and relapse to methamphetamine-seeking behaviour in rats. Neuropharmacology, 58(1), 38-43. [More Information]
  • Kemp, A., Guastella, A. (2010). Oxytocin: Prosocial Behavior, Social Salience, or Approach-Related Behavior? Biological Psychiatry, 67(6), e33-e34. [More Information]
  • Christensen, H., Guastella, A., Mackinnon, A., Griffiths, K., Eagleson, C., Batterham, P., Kalia, K., Kenardy,, J., Bennett, K., Hickie, I. (2010). Protocol for a randomised controlled trial investigating the effectiveness of an online e-health application compared to attention placebo or sertraline in the treatment of generalised anxiety disorder. Trials, 11, 48-1-48-8. [More Information]
  • Carson, D., Hunt, G., Guastella, A., Barber, L., Cornish, J., Arnold, J., Boucher, A., McGregor, I. (2010). Systemically administered oxytocin decreases methamphetamine activation of the subthalamic nucleus and accumbens core and stimulates oxytocinergic neurons in the hypothalamus. Addiction Biology, 15(4), 448-463. [More Information]
  • Guastella, A., Howard, A., Dadds, M., Mitchell, P., Carson, D. (2009). A randomized controlled trial of intranasal oxytocin as an adjunct to exposure therapy for social anxiety disorder. Psychoneuroendocrinology, 34(6), 917-923. [More Information]
  • Guastella, A., Carson, D., Dadds, M., Mitchell, P., Cox, R. (2009). Does oxytocin influence the early detection of angry and happy faces? Psychoneuroendocrinology, 34, 220-225. [More Information]
  • Guastella, A., Dadds, M. (2009). Sequential growth in cognitive-behavioral emotion-processing: A laboratory study. Cognitive Therapy and Research, 33(4), 368-374. [More Information]
  • Guastella, A., Richardson, R., Lovibond, P., Rapee, R., Gaston, J., Mitchell, P., Dadds, M. (2008). A Randomized Controlled Trial of D-Cycloserine Enhancement of Exposure Therapy for Social Anxiety Disorder. Biological Psychiatry, 63(6), 544-549. [More Information]
  • Guastella, A., Dadds, M. (2008). Cognitive-behavioural emotion writing tasks: A controlled trial of multiple processes. Journal of Behavior Therapy and Experimental Psychiatry, 39(4), 558-566. [More Information]
  • Guastella, A., Mitchell, P., Matthews, F. (2008). Oxytocin Enhances the Encoding of Positive Social Memories in Humans. Biological Psychiatry, 64(6), 256-258. [More Information]
  • Guastella, A., Mitchell, P., Dadds, M. (2008). Oxytocin Increases Gaze to the Eye Region of Human Faces. Biological Psychiatry, 63(1), 3-5. [More Information]
  • Unkelbach, C., Guastella, A., Forgas, J. (2008). Oxytocin selectively facilitates recognition of positive sex and relationship words. Psychological Science, 19(11), 1092-1094. [More Information]
  • Dadds, M., El Masry, Y., Wimalaweera, S., Guastella, A. (2008). Reduced Eye Gaze Explains "Fear Blindness" in Childhood Psychopathic Traits. Journal of the American Academy of Child and Adolescent Psychiatry, 47(4), 455-463. [More Information]
  • Guastella, A., Dadds, M., Lovibond, P., Mitchell, P., Richardson, R. (2007). A randomized controlled trial of the effect of D-cycloserine on exposure therapy for spider fear. Journal of Psychiatric Research, 41(6), 466-471. [More Information]
  • Guastella, A., Lovibond, P., Dadds, M., Mitchell, P., Richardson, R. (2007). A randomized controlled trial of the effect of D-cycloserine on extinction and fear conditioning in humans. Behaviour Research and Therapy, 45(4), 663-672. [More Information]
  • Guastella, A., Moulds, M. (2007). The impact of rumination on sleep quality following a stressful life event. Personality and Individual Differences, 42(6), 1151-1162.
  • Guastella, A., Dadds, M. (2006). Cognitive-Behavioral Models of Emotional Writing: A Validation Study. Cognitive Therapy and Research, 30(3), 397-414. [More Information]
  • Roth, J., Dadds, M., McAloon, J., Guastella, A., Weems, C. (2004). Prevalence and Prediction of Disorders in Early Childhood: A Community Study. Behaviour Change, 21(4), 215-228.

2016

  • Alvares, G., Quintana, D., Hickie, I., Guastella, A. (2016). Autonomic nervous system dysfunction in psychiatric disorders and the impact of psychotropic medications: a systematic review and meta-analysis. Journal of Psychiatry & Neuroscience, 40(6), 1-16. [More Information]
  • Iorfino, F., Alvarez, G., Guastella, A., Quintana, D. (2016). Cold face test-induced increases in heart rate variability are abolished by engagement in a social cognition task. Journal of Psychophysiology, 30(1), 38-46. [More Information]
  • Scott, E., Robillard, R., Hermens, D., Naismith, S., Rogers, N., Ip, T., White, D., Guastella, A., Whitwell, B., Smith, K., Hickie, I. (2016). Dysregulated sleep–wake cycles in young people are associated with emerging stages of major mental disorders. Early Intervention in Psychiatry, 10(1), 63-70. [More Information]
  • Guastella, A., Hickie, I. (2016). Oxytocin Treatment, Circuitry and Autism: A Critical Review of the Literature Placing Oxytocin into the Autism Context. Biological Psychiatry, 79(3), 234-242. [More Information]
  • Yatawara, C., Einfeld, S., Hickie, I., Davenport, T., Guastella, A. (2016). The effect of oxytocin nasal spray on social interaction deficits observed in young children with autism: a randomized clinical crossover trial. Molecular Psychiatry, On-line First: 27 Oct 2015(doi:10.1038/mp.2015.162), 1-7. [More Information]
  • Quintana, D., Guastella, A., Westlye, L., Andreassen, O. (2016). The promise and pitfalls of intranasally administering psychopharmacological agents for the treatment of psychiatric disorders. Molecular Psychiatry, 21(1), 29-38. [More Information]

2015

  • Cacciotti-Saija, C., Langdon, R., Ward, P., Hickie, I., Scott, E., Naismith, S., Moore, L., Alvares, G., Redoblado-Hodge, M., Guastella, A. (2015). A Double-blind Randomized Controlled Trial of Oxytocin Nasal Spray and Social Cognition Training for Young People With Early Psychosis. Schizophrenia Bulletin, 41(2), 483-493. [More Information]
  • Guastella, A., Ward, P., Hickie, I., Shahrestani, S., Redoblado Hodge, M., Scott, E., Langdon, R. (2015). A single dose of oxytocin nasal spray improves higher-order social cognition in schizophrenia. Schizophrenia Research, 168(3), 628-633. [More Information]
  • Robillard, R., Hermens, D., Naismith, S., White, D., Rogers, N., Ip, T., Mullin, S., Alvares, G., Guastella, A., Smith, K., Whitwell, B., Southan, J., Glozier, N., Scott, E., Hickie, I., et al (2015). Ambulatory sleep-wake patterns and variability in young people with emerging mental disorders. Journal of Psychiatry & Neuroscience, 40(1), 28-37. [More Information]
  • Chen, N., Clarke, P., Watson, T., MacLeod, C., Guastella, A. (2015). Attentional Bias Modification Facilitates Attentional Control Mechanisms: Evidence from Eye Tracking. Biological Psychology, 104, 139-146. [More Information]
  • Masi, A., Quintana, D., Glozier, N., Lloyd, A., Hickie, I., Guastella, A. (2015). Cytokine aberrations in autism spectrum disorder: a systematic review and meta-analysis. Molecular Psychiatry, 20(4), 440-446. [More Information]
  • Purcell, R., Jorm, A., Hickie, I., Yung, A., Pantelis, C., Aminger, G., Glozier, N., Killackey, E., Phillips, L., Wood, S., Scott, E., Hermens, D., Guastella, A., Kenyon, A., Nichles, A., Zmicerevska, N., et al (2015). Demographic and clinical characteristics of young people seeking help at youth mental health services: baseline findings of the Transitions Study. Early Intervention in Psychiatry, 9(6), 487-497. [More Information]
  • Quintana, D., Alvares, G., Hickie, I., Guastella, A. (2015). Do delivery routes of intranasally administered oxytocin account for observed effects on social cognition and behavior? A two-level model. Neuroscience and Biobehavioral Reviews, 49, 182-192. [More Information]
  • Shahrestani, S., Stewart, E., Quintana, D., Hickie, I., Guastella, A. (2015). Heart rate variability during adolescent and adult social interactions: A meta-analysis. Biological Psychology, 105, 43-50. [More Information]
  • Chen, N., Thomas, L., Clarke, P., Hickie, I., Guastella, A. (2015). Hyperscanning and avoidance in social anxiety disorder: The visual scanpath during public speaking. Psychiatry Research, 225(3), 667-672. [More Information]
  • Masi, A., Lampit, A., Glozier, N., Hickie, I., Guastella, A. (2015). Predictors of placebo response in pharmacological and dietary supplement treatment trials in pediatric autism spectrum disorder: a meta-analysis. Translational Psychiatry, 5, 1-9. [More Information]
  • Howlin, P., Arciuli, J., Begeer, S., Brock, J., Clarke, K., Costley, D., Di Rita, P., Falkmer, T., Glozier, N., Gray, K., Guastella, A., Horstead, S., Rice, L., Stancliffe, R., West, S., Yam, C., Einfeld, S. (2015). Research on adults with autism spectrum disorder: Roundtable report. Journal of Intellectual and Developmental Disability, 40(5), 388-393. [More Information]
  • Guastella, A., Gray, K., Rinehart, N., Alvarez, G., Tonge, B., Hickie, I., Keating, C., Cacciotti-Saija, C., Einfeld, S. (2015). The effects of a course of intranasal oxytocin on social behaviors in youth diagnosed with autism spectrum disorders: a randomized controlled trial. Journal of Child Psychology and Psychiatry, 56(4), 444-452. [More Information]
  • Purcell, R., Jorm, A., Hickie, I., Yung, A., Pantelis, C., Amminger, G., Glozier, N., Killackey, E., Phillips, L., Wood, S., Scott, E., Kenyon, A., Nichles, A., Zmicerevska, N., Hermens, D., Guastella, A., et al (2015). Transitions Study of predictors of illness progression in young people with mental ill health: study methodology. Early Intervention in Psychiatry, 9(1), 38-47. [More Information]

2014

  • O'Dea, B., Glozier, N., Purcell, R., McGorry, P., Scott, J., Feilds, K., Hermens, D., Buchanan, J., Scott, E., Yung, A., Guastella, A., Hickie, I., et al (2014). A cross-sectional exploration of the clinical characteristics of disengaged (NEET) young people in primary mental healthcare. BMJ Open, 4(12), 1-8. [More Information]
  • Einfeld, S., Smith, E., McGregor, I., Steinbeck, K., Taffe, J., Rice, L., Horstead, S., Rogers, N., Hodge, M., Guastella, A. (2014). A Double-Blind Randomized Controlled Trial of Oxytocin Nasal Spray in Prader Willi Syndrome. American Journal of Medical Genetics. Part A, 164A (9), 2232-2239. [More Information]
  • Chen, N., Clarke, P., Watson, T., MacLeod, C., Guastella, A. (2014). Biased Saccadic Responses to Emotional Stimuli in Anxiety: An Antisaccade Study. PloS One, 9(2), 1-7. [More Information]
  • Scott, J., Scott, E., Hermens, D., Naismith, S., Guastella, A., White, D., Whitwell, B., Lagopoulos, J., Hickie, I. (2014). Functional impairment in adolescents and young adults with emerging mood disorders. British Journal of Psychiatry, 205(5), 362-368. [More Information]
  • Shahrestani, S., Stewart, L., Quintana, D., Hickie, I., Guastella, A. (2014). Heart rate variability during social interactions in children with and without psychopathology: a meta-analysis. Journal of Child Psychology and Psychiatry, 55(9), 981-989. [More Information]
  • Alvares, G., Balleine, B., Guastella, A. (2014). Impairments in Goal-Directed Actions Predict Treatment Response to Cognitive-Behavioral Therapy in Social Anxiety Disorder. PloS One, 9(4), 1-7. [More Information]
  • Christensen, H., Mackinnon, A., Batterham, P., O'Dea, B., Guastella, A., Griffiths, K., Eagleson, C., Hehir, K., Kenardy, J., Bennett, K., Hickie, I. (2014). The effectiveness of an online e-health application compared to attention placebo or Sertraline in the treatment of Generalised Anxiety Disorder. Internet Interventions, 1(4), 169-174. [More Information]

2013

  • Carson, D., Guastella, A., Taylor, E., McGregor, I. (2013). A brief history of oxytocin and its role in modulating psychostimulant effects. Journal of Psychopharmacology, 27(3), 231-247. [More Information]
  • Quintana, D., McGregor, I., Guastella, A., Malhi, G., Kemp, A. (2013). A Meta-Analysis on the Impact of Alcohol Dependence on Short-Term Resting-State Heart Rate Variability: Implications for Cardiovascular Risk. Alcoholism: Clinical and Experimental Research, 37(S1), E23-E29. [More Information]
  • Quintana, D., Kemp, A., Alvares, G., Guastella, A. (2013). A role for autonomic cardiac control in the effects of oxytocin on social behavior and psychiatric illness. Frontiers in Neuroscience, 7(April 2013), 1-9. [More Information]
  • Hickie, I., Scott, E., Hermens, D., Naismith, S., Guastella, A., Kaur, M., Sidis, A., Whitwell, B., Glozier, N., Davenport, T., et al (2013). Applying clinical staging to young people who present for mental health care. Early Intervention in Psychiatry, 7(1), 31-43. [More Information]
  • Clarke, P., MacLeod, C., Guastella, A. (2013). Assessing the role of spatial engagement and disengagement of attention in anxiety-linked attentional bias: a critique of current paradigms and suggestions for future research directions. Anxiety Stress and Coping, 26(1), 1-19. [More Information]
  • Hickie, I., Scott, J., Hermens, D., Scott, E., Naismith, S., Guastella, A., Glozier, N., McGorry, P. (2013). Clinical classification in mental health at the cross-roads: which direction next? BMC Medicine, 11(1), 1-14. [More Information]
  • Wudarczyk, O., Earp, B., Guastella, A., Savulescu, J. (2013). Could intranasal oxytocin be used to enhance relationships? Research imperatives, clinical policy, and ethical considerations. Current Opinion in Psychiatry, 26(5), 474-484. [More Information]
  • Scott, E., Hermens, D., Naismith, S., Guastella, A., De Regt, T., White, D., Lagopoulos, J., Hickie, I. (2013). Distinguishing young people with emerging bipolar disorders from those with unipolar depression. Journal of Affective Disorders, 144(3), 208-215. [More Information]
  • Scott, E., Hermens, D., Naismith, S., Guastella, A., White, D., Whitwell, B., Lagopoulos, J., Scott, J., Hickie, I. (2013). Distress and disability in young adults presenting to clinical services with mood disorders. International Journal of Bipolar Disorders, 1, 1-8. [More Information]
  • McCade, D., Savage, G., Guastella, A., Lewis, S., Naismith, S. (2013). Emotion Recognition Deficits Exist in Mild Cognitive Impairment, But Only in the Amnestic Subtype. Psychology and Aging, 28(3), 840-852. [More Information]
  • McCade, D., Savage, G., Guastella, A., Hickie, I., Lewis, S., Naismith, S. (2013). Emotion Recognition in Mild Cognitive Impairment: Relationship to Psychosocial Disability and Caregiver Burden. Journal of Geriatric Psychiatry and Neurology, 26(3), 165-173. [More Information]
  • Hickie, I., Hermens, D., Naismith, S., Guastella, A., Glozier, N., Scott, J., Scott, E. (2013). Evaluating differential developmental trajectories to adolescent-onset mood and psychotic disorders. BMC Psychiatry, 13(1), 1-11. [More Information]
  • Liu, J., Guastella, A., Dadds, M. (2013). Exploring the role of intra-nasal oxytocin on the partner preference effect in humans. Psychoneuroendocrinology, 38(4), 587-591. [More Information]
  • Quintana, D., Guastella, A., McGregor, I., Hickie, I., Kemp, A. (2013). Heart rate variability predicts alcohol craving in alcohol dependent outpatients: Further evidence for HRV as a psychophysiological marker of self-regulation. Drug and Alcohol Dependence, 132(1-2), 395-398. [More Information]
  • Quintana, D., Guastella, A., McGregor, I., Hickie, I., Kemp, A. (2013). Moderate alcohol intake is related to increased heart rate variability in young adults: Implications for health and well-being. Psychophysiology, 50(12), 1202-1208. [More Information]
  • Hermens, D., Naismith, S., Lagopoulos, J., Lee, R., Guastella, A., Scott, E., Hickie, I. (2013). Neuropsychological profile according to the clinical stage of young persons presenting for mental health care. BMC Psychology, 1, 1-9. [More Information]
  • Guastella, A., Hickie, I., McGuinness, M., Otis, M., Woods, E., Disinger, H., Chan, K., Chen, T., Banati, R. (2013). Recommendations for the standardisation of oxytocin nasal administration and guidelines for its reporting in human research. Psychoneuroendocrinology, 38(5), 612-625. [More Information]
  • Alvares, G., Quintana, D., Kemp, A., van Zwieten, A., Balleine, B., Hickie, I., Guastella, A. (2013). Reduced heart rate variability in social anxiety disorder: associations with gender and symptom severity. PloS One, 8(7), 1-8. [More Information]
  • van Zwieten, A., Meyer, J., Hermens, D., Hickie, I., Hawes, D., Glozier, N., Naismith, S., Scott, E., Lee, R., Guastella, A. (2013). Social cognition deficits and psychopathic traits in young people seeking mental health treatment. PloS One, 8(7), 1-9. [More Information]
  • Guastella, A., Hermens, D., van Zwieten, A., Naismith, S., Lee, R., Cacciotti-Saija, C., Scott, E., Hickie, I. (2013). Social cognitive performance as a marker of positive psychotic symptoms in young people seeking help for mental health problems. Schizophrenia Research, 149(1-3), 77-82. [More Information]
  • Shahrestani, S., Kemp, A., Guastella, A. (2013). The Impact of a Single Administration of Intranasal Oxytocin on the Recognition of Basic Emotions in Humans: A Meta-Analysis. Neuropsychopharmacology, 38(10), 1929-1936. [More Information]
  • Guastella, A., Alvares, G., Hickie, I., Chan, K., Chen, T., Banati, R. (2013). Unitary hormonal models, peripheral markers, and evaluation of response to drug: A response to Weisman and Feldman. Psychoneuroendocrinology, 38, 627-628. [More Information]

2012

  • Lowe (nee Thompson), R., Guastella, A., Chen, N., Menzies, R., Packman, A., O'Brian, S., Onslow, M. (2012). Avoidance of eye gaze by adults who stutter. Journal of Fluency Disorders, 37(4), 263-274. [More Information]
  • Chen, N., Clarke, P., MacLeod, C., Guastella, A. (2012). Biased Attentional Processing of Positive Stimuli in Social Anxiety Disorder: An Eye Movement Study. Cognitive Behaviour Therapy, 41(2), 96-107. [More Information]
  • Clarke, P., Hickie, I., Scott, E., Guastella, A. (2012). Clinical staging model applied to young people presenting with social anxiety. Early Intervention in Psychiatry, 6(3), 256-264. [More Information]
  • Liu, J., Guastella, A., Dadds, M. (2012). Effects of oxytocin on human social approach measured using intimacy equilibriums. Hormones and Behavior, 62(5), 585-591. [More Information]
  • Quintana, D., Guastella, A., Outhred, T., Hickie, I., Kemp, A. (2012). Heart Rate Variability is Associated With Emotion Recognition: Direct Evidence for a Relationship Between the Autonomic Nervous System and Social Cognition. International Journal of Psychophysiology, 86(2), 168-172. [More Information]
  • Bryant, R., Hung, L., Guastella, A., Mitchell, P. (2012). Oxytocin as a moderator of hypnotizability. Psychoneuroendocrinology, 37(1), 162-166. [More Information]
  • Kemp, A., Quintana, D., Kuhnert, R., Griffiths, K., Hickie, I., Guastella, A. (2012). Oxytocin increases heart rate variability in humans at rest: implications for social approach-related motivation and capacity for social engagement. PloS One, 7(8), 1-6. [More Information]
  • Alvares, G., Chen, N., Balleine, B., Hickie, I., Guastella, A. (2012). Oxytocin selectively moderates negative cognitive appraisals in high trait anxious males. Psychoneuroendocrinology, 37(12), 2022-2031. [More Information]
  • Clarke, P., Chen, N., Guastella, A. (2012). Prepared for the Best: Readiness To Modify Attentional Processing and Reduction in Anxiety Vulnerability in Response to Therapy. Emotion, 12(3), 487-494. [More Information]
  • Scott, E., Hermens, D., Glozier, N., Naismith, S., Guastella, A., Hickie, I. (2012). Targeted primary care-based mental health services for young Australians. Medical Journal of Australia, 196(2), 136-140. [More Information]
  • Scott, E., Hermens, D., Naismith, S., White, D., Whitwell, B., Guastella, A., Glozier, N., Hickie, I. (2012). Thoughts of death or suicidal ideation are common in young people aged 12 to 30 years presenting for mental health care. BMC Psychiatry, 12(December 2012), 1-6. [More Information]

2011

  • Guastella, A., Kenyon, A., Unkelbach, C., Alvares, G., Hickie, I. (2011). Arginine Vasopressin selectively enhances recognition of sexual cues in male humans. Psychoneuroendocrinology, 36(2), 294-297. [More Information]
  • Kemp, A., Guastella, A. (2011). The Role of Oxytocin in Human Affect: A Novel Hypothesis. Current Directions in Psychological Science, 20(4), 222-231.
  • Kemp, A., Guastella, A. (2011). The Role of Oxytocin in Human Affect: A Novel Hypothesis. Current Directions in Psychological Science, 20(4), 222-231. [More Information]

2010

  • Alvares, G., Hickie, I., Guastella, A. (2010). Acute effects of intranasal oxytocin on subjective and behavioral responses to social rejection. Experimental and Clinical Psychopharmacology, 18(4), 316-321. [More Information]
  • Guastella, A., Kenyon, A., Alvares, G., Carson, D., Hickie, I. (2010). Intranasal Arginine Vasopressin Enhances the Encoding of Happy and Angry Faces in Humans. Biological Psychiatry, 67(12), 1220-1222. [More Information]
  • Guastella, A., Einfeld, S., Gray, K., Rinehart, N., Tonge, B., Lambert, T., Hickie, I. (2010). Intranasal Oxytocin Improves Emotion Recognition in Youth with Autism Spectrum Disorders. Biological Psychiatry, 67, 692-694. [More Information]
  • Carson, D., Cornish, J., Guastella, A., Hunt, G., McGregor, I. (2010). Oxytocin decreases methamphetamine self-administration, methamphetamine hyperactivity, and relapse to methamphetamine-seeking behaviour in rats. Neuropharmacology, 58(1), 38-43. [More Information]
  • Kemp, A., Guastella, A. (2010). Oxytocin: Prosocial Behavior, Social Salience, or Approach-Related Behavior? Biological Psychiatry, 67(6), e33-e34. [More Information]
  • Christensen, H., Guastella, A., Mackinnon, A., Griffiths, K., Eagleson, C., Batterham, P., Kalia, K., Kenardy,, J., Bennett, K., Hickie, I. (2010). Protocol for a randomised controlled trial investigating the effectiveness of an online e-health application compared to attention placebo or sertraline in the treatment of generalised anxiety disorder. Trials, 11, 48-1-48-8. [More Information]
  • Carson, D., Hunt, G., Guastella, A., Barber, L., Cornish, J., Arnold, J., Boucher, A., McGregor, I. (2010). Systemically administered oxytocin decreases methamphetamine activation of the subthalamic nucleus and accumbens core and stimulates oxytocinergic neurons in the hypothalamus. Addiction Biology, 15(4), 448-463. [More Information]

2009

  • Guastella, A., Howard, A., Dadds, M., Mitchell, P., Carson, D. (2009). A randomized controlled trial of intranasal oxytocin as an adjunct to exposure therapy for social anxiety disorder. Psychoneuroendocrinology, 34(6), 917-923. [More Information]
  • Guastella, A., Carson, D., Dadds, M., Mitchell, P., Cox, R. (2009). Does oxytocin influence the early detection of angry and happy faces? Psychoneuroendocrinology, 34, 220-225. [More Information]
  • Guastella, A., Dadds, M. (2009). Sequential growth in cognitive-behavioral emotion-processing: A laboratory study. Cognitive Therapy and Research, 33(4), 368-374. [More Information]

2008

  • Guastella, A., Richardson, R., Lovibond, P., Rapee, R., Gaston, J., Mitchell, P., Dadds, M. (2008). A Randomized Controlled Trial of D-Cycloserine Enhancement of Exposure Therapy for Social Anxiety Disorder. Biological Psychiatry, 63(6), 544-549. [More Information]
  • Guastella, A., Dadds, M. (2008). Cognitive-behavioural emotion writing tasks: A controlled trial of multiple processes. Journal of Behavior Therapy and Experimental Psychiatry, 39(4), 558-566. [More Information]
  • Guastella, A., Mitchell, P., Matthews, F. (2008). Oxytocin Enhances the Encoding of Positive Social Memories in Humans. Biological Psychiatry, 64(6), 256-258. [More Information]
  • Guastella, A., Mitchell, P., Dadds, M. (2008). Oxytocin Increases Gaze to the Eye Region of Human Faces. Biological Psychiatry, 63(1), 3-5. [More Information]
  • Unkelbach, C., Guastella, A., Forgas, J. (2008). Oxytocin selectively facilitates recognition of positive sex and relationship words. Psychological Science, 19(11), 1092-1094. [More Information]
  • Dadds, M., El Masry, Y., Wimalaweera, S., Guastella, A. (2008). Reduced Eye Gaze Explains "Fear Blindness" in Childhood Psychopathic Traits. Journal of the American Academy of Child and Adolescent Psychiatry, 47(4), 455-463. [More Information]

2007

  • Guastella, A., Dadds, M., Lovibond, P., Mitchell, P., Richardson, R. (2007). A randomized controlled trial of the effect of D-cycloserine on exposure therapy for spider fear. Journal of Psychiatric Research, 41(6), 466-471. [More Information]
  • Guastella, A., Lovibond, P., Dadds, M., Mitchell, P., Richardson, R. (2007). A randomized controlled trial of the effect of D-cycloserine on extinction and fear conditioning in humans. Behaviour Research and Therapy, 45(4), 663-672. [More Information]
  • Guastella, A., Moulds, M. (2007). The impact of rumination on sleep quality following a stressful life event. Personality and Individual Differences, 42(6), 1151-1162.

2006

  • Guastella, A., Dadds, M. (2006). Cognitive-Behavioral Models of Emotional Writing: A Validation Study. Cognitive Therapy and Research, 30(3), 397-414. [More Information]

2004

  • Roth, J., Dadds, M., McAloon, J., Guastella, A., Weems, C. (2004). Prevalence and Prediction of Disorders in Early Childhood: A Community Study. Behaviour Change, 21(4), 215-228.

To update your profile click here. For support on your academic profile contact .